Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05142592 |
| Title | IPG7236 in Patients With Advanced Solid Tumors |
| Recruitment | Completed |
| Gender | |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Nanjing Immunophage Biotech Co., Ltd |
| Indications | |
| Therapies | |
| Age Groups: | |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Providence Portland Medical Center | Portland | Oregon | 97222 | United States | Details | |
| NEXT Oncology | Austin | Texas | 12221 | United States | Details | |
| The First Affiliated Hospital Nanchang Univeristy | Nanchang | Jiangxi | China | Details | ||
| Shandong Cancer Hospital | Jinan | Shangdong | China | Details | ||
| Shanghai East Hospital | Shanghai | China | Details | |||
| Shanghai General Hospital | Shanghai | China | Details | |||
| Shanghai GoBroad Cancer Hospital China Pharmaceutical University | Shanghai | China | Details |